SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.95-0.7%9:47 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (18732)4/6/1998 10:34:00 PM
From: Machaon  Read Replies (7) of 32384
 
<====================================================================

<< Among the group on the drug, there were 33 cases of cancer of the uterine lining, vs. 14 cases in the placebo group.

The drug group had 17 cases of blood clots in the lung, including two deaths. This compares with six cases and no deaths among the placebo group.

In the drug group, there were 30 cases of blood clots in major veins, compared with 19 cases in the placebo group. In some women, tamoxifen also causes hot flashes and vaginal discharge, officials said.
>>
===================================================================>

The high price paid, sometimes, when one becomes part of a double blind study. However, for the majority of enrollees, it certainly seemed to offer them some hope.

Henry, what's your overall reaction to the CNN broadcast, and the subsequent news coverage?

Thanks, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext